|
Muntéis Olivas E, Navarro Mascarell G, Meca Lallana J, Maestre Martínez A, Pérez Sempere Á, Gracia Gil J, Pato Pato A. Cultural adaptation and validation of a peninsular Spanish version of the MSTCQ(©) (Multiple Sclerosis Treatment Concerns Questionnaire). Neurologia. 2015 Feb 16. pii: S0213-4853(15)00006-7. doi: 10.1016/j.nrl.2014.12.011. [Epub ahead of print] English, Spanish. PubMed PMID: 25697827.
AÑO: 2015; IF: 1.79
|
25697827
|
Meca-Lallana JE, Carreón-Guarnizo E, Hernández-Clares R, García-Molina E, Díaz-Pérez J, Leon-Hernández A, Zamarro-Parra J, Martín-Fernández JJ. Clinical and radiological control of highly active relapsing-remitting multiple sclerosis with first-line natalizumab. Neurodegener Dis Manag. 2017 Jun;7(3):175-181. doi: 10.2217/nmt-2017-0007. Epub 2017 Jun 8. PubMed PMID: 28592169.
AÑO: 2017
|
|
Meca-Lallana JE, Prieto-Gonzalez JM, Jimenez-Veiga J, Carreon-Guarnizo E, Jimenez-Martin I, Hernandez-Clares R, Sistiaga-Berrondo A, Carles-Dies R, Garcia-Molina E, Cerdan-Sanchez M, Costa-Arpin E, Croitoru I, Castillo-Trivino T, Iniesta-Martinez F, Garcia-Perez E, Olascoaga-Urtaza J. Development and validation of a brief electronic screening test for cognitive impairment in multiple sclerosis (SCI-MS Test). Mult Scler Relat Disord. 2019 Feb;28:50-56. doi: 10.1016/j.msard.2018.12.003. Epub 2018 Dec 3. PubMed PMID: 30553169.
AÑO: 2019; IF: 2.889
|
|
Espiño M, Abraira V, Arroyo R, Bau L, Cámara C, Campos-Ruiz L, Casanova B, Espejo C, Fernández O, García-Merino A, García-Sánchez MI, Gómez M, Gosis A, Izquierdo G, Meca J, Montalban X, Morandeira F, Olascoaga J, Prada A, Quintana E, Ramió-Torrentà L, Rodríguez-Antigüedad A, Salgado G, Santiago JL, Sarasola E, Simó-Castelló M, Alvarez-Cermeño JC, Villar LM. Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice. Clin Chim Acta. 2015 Jan 1;438:67-9. doi: 10.1016/j.cca.2014.08.004. Epub 2014 Aug 8. PubMed PMID: 25110815.
AÑO: 2015; IF: 2.926
|
|
Carreon Guarnizo E, Hernandez Clares R, Castillo Trivino T, Meca Lallana V, Arocas Casan V, Iniesta Martinez F, Olascoaga Urtaza J, Meca Lallana JE. Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders. Neurologia (Engl Ed). 2022 Apr;37(3):178-183. doi: 10.1016/j.nrl.2018.12.013. Epub 2019 Mar 28. English, Spanish. PubMed PMID: 30928236.
AÑO: 2022; IF: 2.283
|